Literature DB >> 30614561

Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications.

Guangbao Yang1, Soo Zeng Fiona Phua1, Anivind Kaur Bindra1, Yanli Zhao1,2.   

Abstract

Inorganic nanoparticles with tunable and diverse properties hold tremendous potential in the field of nanomedicine, while having non-negligible toxicity concerns in healthy tissues/organs that have resulted in their restricted clinical translation to date. In the past decade, the emergence of biodegradable or clearable inorganic nanoparticles has made it possible to completely solve this long-standing conundrum. A comprehensive understanding of the design of these inorganic nanoparticles with their metabolic performance in the body is of crucial importance to advance clinical trials and expand their biological applications in disease diagnosis. Here, a diverse variety of biodegradable or clearable inorganic nanoparticles regarding considerations of the size, morphology, surface chemistry, and doping strategy are highlighted. Their pharmacokinetics, pathways of metabolism in the body, and time required for excretion are discussed. Some inorganic materials intrinsically responsive to various conditions in the tumor microenvironment are also introduced. Finally, an overview of the encountered challenges is provided along with an outlook for applying these inorganic nanoparticles toward future clinical translations.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biomedicine; excretion; inorganic nanoparticles; metabolism; pharmacokinetics

Mesh:

Substances:

Year:  2019        PMID: 30614561     DOI: 10.1002/adma.201805730

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  32 in total

Review 1.  Mechanisms of immune response to inorganic nanoparticles and their degradation products.

Authors:  Raziye Mohammapdour; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2021-11-02       Impact factor: 15.470

2.  Renally Excretable Silver Telluride Nanoparticles as Contrast Agents for X-ray Imaging.

Authors:  Lenitza M Nieves; Yuxi C Dong; Derick N Rosario-Berríos; Katherine Mossburg; Jessica C Hsu; Gwendolyn M Cramer; Theresa M Busch; Andrew D A Maidment; David P Cormode
Journal:  ACS Appl Mater Interfaces       Date:  2022-07-22       Impact factor: 10.383

3.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

Review 4.  Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives.

Authors:  Madhusudhan Alle; Garima Sharma; Seung-Hwan Lee; Jin-Chul Kim
Journal:  J Nanobiotechnology       Date:  2022-07-02       Impact factor: 9.429

Review 5.  Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma.

Authors:  Danping Zhuang; Huifen Zhang; Genwen Hu; Bing Guo
Journal:  J Nanobiotechnology       Date:  2022-06-16       Impact factor: 9.429

Review 6.  Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

Authors:  Gan Luo; Jue Zhang; Yaqi Sun; Ya Wang; Hanbin Wang; Baoli Cheng; Qiang Shu; Xiangming Fang
Journal:  Nanomicro Lett       Date:  2021-03-08

7.  Intracellular Activation of Anticancer Therapeutics Using Polymeric Bioorthogonal Nanocatalysts.

Authors:  Xianzhi Zhang; Ryan F Landis; Puspam Keshri; Roberto Cao-Milán; David C Luther; Sanjana Gopalakrishnan; Yuanchang Liu; Rui Huang; Gengtan Li; Morgane Malassiné; Imad Uddin; Brayan Rondon; Vincent M Rotello
Journal:  Adv Healthc Mater       Date:  2020-12-13       Impact factor: 9.933

Review 8.  Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations.

Authors:  Valentina Colapicchioni; Francesco Millozzi; Ornella Parolini; Daniela Palacios
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-29

9.  Biodegradable Nickel Disulfide Nanozymes with GSH-Depleting Function for High-Efficiency Photothermal-Catalytic Antibacterial Therapy.

Authors:  Xianwen Wang; Linxin Fan; Liang Cheng; Yanbin Sun; Xiyu Wang; Xiaoyan Zhong; Qianqian Shi; Fei Gong; Yu Yang; Yan Ma; Zhaohua Miao; Zhengbao Zha
Journal:  iScience       Date:  2020-06-16

10.  Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy.

Authors:  Tobias Sonntag; Franziska Froemel; W Daniel Stamer; Andreas Ohlmann; Rudolf Fuchshofer; Miriam Breunig
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.